WeTrials
Recruiting

The Phase III 'High Five Trial' Five Fraction Radiation For High-Risk Prostate Cancer

What is this study?

This study is comparing two different types of radiation therapy for high-risk prostate cancer. Researchers want to see if a shorter, highly focused radiation treatment can fight the cancer just as well as standard, longer radiation treatments.

Who can participate?

You may be able to join if you have been diagnosed with high-risk prostate cancer that has not spread to distant parts of the body. Doctors will check specific lab results, such as your PSA levels and tumor grade, to see if you qualify.

What will happen?

Depending on the group you are placed in, you will receive either a shorter course of radiation over two weeks or standard radiation over several weeks. You will also have regular check-ins, imaging scans, and answer simple surveys about how you are feeling.

Where and when?

This study is recruiting at more than 400 sites across the United States and 9 sites in Canada. Your care team can help you find the most convenient location for your visits.

Key Points
  • 1Tests a shorter radiation schedule against standard radiation therapy
  • 2Aims to make treatment more convenient without losing effectiveness
  • 3Currently recruiting men with high-risk prostate cancer at more than 400 sites in the US and Canada

Related videos

2

NRG Oncology: study chair Karen Hoffman introduces the High Five trial (2024)

Prostate Cancer Radiation: New Guideline Says Fewer Sessions Work Just as Well

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.